search
Back to results

Newborn Vitamin A (VA) Supplementation Pilot Project, Pakistan (VA)

Primary Purpose

Vitamin A Deficiency

Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Vitamin A
Placebo
Sponsored by
Aga Khan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Vitamin A Deficiency focused on measuring IMR, Newborn Mortality, Vitamin A Effectiveness, Premature Mortality, Mortality

Eligibility Criteria

undefined - 15 Days (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Live born infants from all pregnancies within participating villages will be eligible for enrollment in this study.

Exclusion Criteria:

  • Child born with congenital malformation
  • Serious birth injury
  • Neonates with birth asphyxia and serious infections
  • Gestational age less than 32 weeks
  • Birth weight less than 1500 gms
  • Refusal by parents to participate

Sites / Locations

  • Project Office

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

1

2

Arm Description

Routine Post-partum Care and Vitamin A supplementation (50,000 IU) to the Newborn

Routine Post-partum Care with Placebo to the Newborn

Outcomes

Primary Outcome Measures

Primary outcome is reduction in Infant Mortality less than six months of age

Secondary Outcome Measures

Secondary outcomes includes reduction in the incidence of diarrhea, ARI and Sepsis

Full Information

First Posted
May 6, 2008
Last Updated
August 9, 2011
Sponsor
Aga Khan University
Collaborators
John Snow, Inc., Pakistan Ministry of Health, Save the Children, London School of Hygiene and Tropical Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT00674089
Brief Title
Newborn Vitamin A (VA) Supplementation Pilot Project, Pakistan
Acronym
VA
Official Title
Evaluation of the Effectiveness of Vitamin A Supplementation (VAS) as Part of a Neonatal Post Partum Care Package in Rural Pakistan
Study Type
Interventional

2. Study Status

Record Verification Date
October 2010
Overall Recruitment Status
Completed
Study Start Date
January 2007 (undefined)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
October 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Aga Khan University
Collaborators
John Snow, Inc., Pakistan Ministry of Health, Save the Children, London School of Hygiene and Tropical Medicine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Vitamin A is an essential micronutrient for the normal functioning of the visual system, growth and development, immunity and reproduction. Its deficiency causes anemia, growth retardation and xerophthalmia. Vitamin A deficiency also increases the incidence and/or severity of infectious episodes and affects child survival. Reduced child survival is the most severe and potentially the most widespread consequence of Vitamin A deficiency. Improvement in vitamin A status is now regarded as one of the most cost effective preventive measures for the reduction of child mortality and morbidity. Over the past decade several studies have examined the effect of vitamin A on reducing mortality among children aged ≥6months at the time of intervention. Impact of vitamin A supplementation can significantly reduce total mortality but it is only established through supplementation programs in children age 6 months or older. It was assumed that breast milk protects infants from vitamin A deficiency, but recent evidence has challenged this. Infants born with low stores of vitamin A and if the mother breast milk has a low concentration of vitamin A, as found in developing countries, the infants might be unable to meet their daily requirements and improve body reserves. There is association between mortality and degree of vitamin A deficiency, greater the degree of deficiency, higher the mortality. The role of vitamin A in child survival is now well established and over 60 countries have vitamin A supplementation programs nationally. However, most are still using vitamin A supplements in the second half of infancy, even though over 75% of all under 5 deaths take place in the first 6 months of life. If neonatal vitamin A supplementation can be found to be effective and a service delivery mechanism also found, this will represent a major advance in reaching the MDG 4 targets. This is thus persuasive reason to explore this particular preventive strategy, especially in terms of packaging with other postnatal care activities. However, given that in some instances it has been difficult to disentangle the effect of vitamin A dosing from concomitant vaccinations such as BCG, the current evidence needs further evaluation in effectiveness settings. We propose to evaluate the effectiveness of early neonatal vitamin A administration (single dose 50,000 units) to the newborn to see its effect on infant mortality less than 6 months of age as part of postnatal package through National Program. Government has launched the National Program for Family Planning and Primary Health Care since April 1994. Primarily it is being implemented in the community through Lady Health Workers (LHWs) of the National Program. The LHWs are females, with a minimum of eight years of education, residents of the locality in which they are working. The Programme is being currently implemented in all the districts throughout the country and 93,000 LHWs are working covering primarily women and children of the rural population. These LHWs deliver services related to family planning, maternal and child health, immunization, nutrition and treatment of minor ailments to her average registered population of 100-150 households or ~1000 population. Over 3,000 Supervisors have been recruited and trained to supervise the work of LHWs.
Detailed Description
Goal: To reduce the infant mortality rate in rural Pakistan through evidence based interventions. Aim: To evaluate the impact of a community-based neonatal Vitamin A supplementation program on the morbidity and mortality in newborns and young infants (1-6 months of age) when administered at community level Primary objectives: To evaluate the effectiveness of a single dose 50,000 IU of vitamin A supplementation to newborn infants within 48 hours after birth in rural Punjab and Sindh in reducing mortality (<6 months of age) by ≥ 25%. To evaluate the feasibility of neonatal vitamin A dosing when administered by LHW as part of postnatal care package Methodology: Study Design: Community based, cluster randomized, double blinded, placebo control trial Sample size estimation: Assuming average infant mortality rate 40 per thousand live births in the proposed clusters without intervention (range 30-50/1000 live births), and a targeted 25% reduction in mortality in first six months of life, (5% significance level and 80% power) our estimates indicate that the trial will require total 360 clusters [180 in each arm]. The average population size and birth rate per LHW are 1000 and 30 respectively Study Site: Districts Sukkhur and Jehlum. Both the districts, represent a typical mix of peri-urban and rural, multiethnic population of Pakistan. Although a public health care infrastructure exists, it is notable that almost 60% of the population seeks care from private health sector. Current rates of immunizations are poor (approximately 60%) and largely population is illiterate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin A Deficiency
Keywords
IMR, Newborn Mortality, Vitamin A Effectiveness, Premature Mortality, Mortality

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
7400 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Routine Post-partum Care and Vitamin A supplementation (50,000 IU) to the Newborn
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Routine Post-partum Care with Placebo to the Newborn
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin A
Intervention Description
Vitamin A 50,000 IU
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Vitamin A Placebo
Primary Outcome Measure Information:
Title
Primary outcome is reduction in Infant Mortality less than six months of age
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Secondary outcomes includes reduction in the incidence of diarrhea, ARI and Sepsis
Time Frame
2 years

10. Eligibility

Sex
All
Maximum Age & Unit of Time
15 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Live born infants from all pregnancies within participating villages will be eligible for enrollment in this study. Exclusion Criteria: Child born with congenital malformation Serious birth injury Neonates with birth asphyxia and serious infections Gestational age less than 32 weeks Birth weight less than 1500 gms Refusal by parents to participate
Facility Information:
Facility Name
Project Office
City
Sukkur
State/Province
Sindh
ZIP/Postal Code
75300
Country
Pakistan

12. IPD Sharing Statement

Citations:
PubMed Identifier
27471856
Citation
Soofi S, Ariff S, Sadiq K, Habib A, Bhatti Z, Ahmad I, Hussain M, Ali N, Cousens S, Bhutta ZA. Evaluation of the uptake and impact of neonatal vitamin A supplementation delivered through the Lady Health Worker programme on neonatal and infant morbidity and mortality in rural Pakistan: an effectiveness trial. Arch Dis Child. 2017 Mar;102(3):216-223. doi: 10.1136/archdischild-2016-310542. Epub 2016 Jun 28.
Results Reference
derived

Learn more about this trial

Newborn Vitamin A (VA) Supplementation Pilot Project, Pakistan

We'll reach out to this number within 24 hrs